BIOSYENT INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.18 CAD | +0.33% |
|
+1.44% | -0.43% |
| 05-17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
| 05-17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 78.69M | - | - | - | |||
| 765B | ||||||
| 354B | - | - | - | - | ||
| 331B | ||||||
| 299B | ||||||
| 248B |
- Stock Market
- Equities
- RX Stock
- Charts BioSyent Inc.
- Sector Chart